Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-014575
Filing Date
2021-03-10
Accepted
2021-03-10 16:06:48
Documents
62
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_tffpharma.htm 10-K 815380
2 DESCRIPTION OF CAPITAL STOCK f10k2020ex4-4_tffpharma.htm EX-4.4 7498
3 EMPLOYMENT AGREEMENT DATED SEPTEMBER 24, 2020 BY AND BETWEEN THE REGISTRANT AND f10k2020ex10-11_tffpharma.htm EX-10.11 53794
4 CONSENT OF MARCUM LLP f10k2020ex23-1_tffpharma.htm EX-23.1 2155
5 CERTIFICATION f10k2020ex31-1_tffpharma.htm EX-31.1 10136
6 CERTIFICATION f10k2020ex31-2_tffpharma.htm EX-31.2 10391
7 CERTIFICATION f10k2020ex32-1_tffpharma.htm EX-32.1 6242
8 GRAPHIC img_001.jpg GRAPHIC 4721
9 GRAPHIC img_002.jpg GRAPHIC 52278
  Complete submission text file 0001213900-21-014575.txt   3645949

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE tffp-20201231.xml EX-101.INS 396846
11 XBRL SCHEMA FILE tffp-20201231.xsd EX-101.SCH 57399
12 XBRL CALCULATION FILE tffp-20201231_cal.xml EX-101.CAL 20221
13 XBRL DEFINITION FILE tffp-20201231_def.xml EX-101.DEF 201686
14 XBRL LABEL FILE tffp-20201231_lab.xml EX-101.LAB 417924
15 XBRL PRESENTATION FILE tffp-20201231_pre.xml EX-101.PRE 215358
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39102 | Film No.: 21729731
SIC: 2834 Pharmaceutical Preparations